Mariko Imazeki

Title: Mariko Imazeki: Innovator in Pharmaceutical Chemistry

Introduction

Mariko Imazeki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. Her work focuses on addressing various health conditions through innovative drug formulations.

Latest Patents

Mariko Imazeki holds a patent for a pyrazole derivative. This compound, expressed by formula (I), or a pharmacologically permissible salt thereof, serves as an active ingredient in drug compositions. It exhibits a xanthine oxidase inhibiting effect, which is beneficial for treating or preventing diseases associated with xanthine oxidase, such as gout, hyperuricemia, and cardiovascular diseases. The patent highlights the compound's potential in addressing a range of health issues, including renal disease and autoimmune diseases.

Career Highlights

Imazeki is currently employed at Teijin Pharma Limited, where she continues to advance her research and development efforts. Her innovative approach to drug formulation has positioned her as a key player in the pharmaceutical industry. With a focus on improving patient outcomes, she is dedicated to exploring new therapeutic avenues.

Collaborations

Mariko collaborates with esteemed colleagues, including Asahi Kawana and Chikashi Kanazawa. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Mariko Imazeki is a trailblazer in the field of pharmaceutical chemistry, with a focus on developing innovative compounds for various health conditions. Her contributions through her patent and collaborations reflect her commitment to advancing medical science.